New Jersey Assembly Bill A5855

New Jersey 2024-2025 Regular Session

• Introduced: 6/19/25
• Refer: 6/19/25

Caption

Increases penalty for crime of manufacturing, distributing, or dispensing certain Schedule I or II controlled dangerous substances.

Impact

If enacted, A5855 will affect existing laws pertaining to controlled dangerous substances by reclassifying the degrees of crime associated with drug offenses. Under current law, manufacturing, distributing, or dispensing certain narcotics is considered a second-degree crime if the quantity is one ounce or more. The proposed legislation will elevate this to a first-degree crime when the quantity is one ounce or more, with accompanying increases in potential prison sentences and fines. This change reflects a more aggressive stance towards fentanyl and likely aims to deter drug trafficking offenses.

Summary

Assembly Bill A5855 aims to revise penalties for the manufacturing, distributing, or dispensing of certain Schedule I and II controlled dangerous substances, with a specific focus on fentanyl-related crimes. The bill proposes to align the penalties for fentanyl more closely with those for heroin, acknowledging the former's increased potency and associated dangers. The intent is to mitigate disparities in legal consequences, which may currently incentivize individuals to exploit fentanyl's higher profitability, thereby posing elevated risks to public safety.

Contention

Critics of the bill may raise concerns regarding the implications of stricter penalties on offenders, particularly in regard to potential prison overcrowding and the long-term effectiveness of harsh penalties as a deterrent against drug-related crime. Opponents may argue that a more nuanced approach towards addiction treatment and rehabilitation may prove more beneficial than escalating penalties. Discussions surrounding A5855 highlight the ongoing debate between addressing the opioid crisis through punitive measures versus focusing on public health outcomes.